Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Fluidigm Corporation (FLDM) stocks in Canada

Learn how to easily invest in Fluidigm Corporation stocks.

Fluidigm Corporation is a diagnostics & research business based in the US. Fluidigm Corporation stocks (FLDM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.12 – a decrease of 1.41% over the previous week. Fluidigm Corporation employs 627 staff and has a trailing 12-month revenue of around $136.9 million.

How to buy shares in Fluidigm Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FLDM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Fluidigm Corporation stock price (NASDAQ:FLDM)

Use our graph to track the performance of FLDM stocks over time.

Fluidigm Corporation shares at a glance

Information last updated 2022-01-25.
Latest market close$2.80
52-week range$2.67 - $7.51
50-day moving average $3.95
200-day moving average $5.39
Wall St. target price$10.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.90

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Fluidigm Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Fluidigm Corporation price performance over time

Historical closes compared with the close of $2.8 from 2022-01-27

1 week (2022-01-21) -1.41%
1 month (2021-12-28) -22.87%
3 months (2021-10-28) -44.55%
6 months (2021-07-28) -60.56%
1 year (2021-01-28) -57.06%
2 years (2020-01-28) -31.87%
3 years (2019-01-28) 8.89
5 years (2017-01-27) 6.23

Is Fluidigm Corporation under- or over-valued?

Valuing Fluidigm Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fluidigm Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Fluidigm Corporation's PEG ratio

Fluidigm Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fluidigm Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Fluidigm Corporation financials

Revenue TTM $136.9 million
Gross profit TTM $46.9 million
Return on assets TTM -15.1%
Return on equity TTM -53.98%
Profit margin -49.54%
Book value $1.30
Market capitalisation $227.9 million

TTM: trailing 12 months

Fluidigm Corporation share dividends

We're not expecting Fluidigm Corporation to pay a dividend over the next 12 months.

Fluidigm Corporation share price volatility

Over the last 12 months, Fluidigm Corporation's shares have ranged in value from as little as $2.67 up to $7.51. A popular way to gauge a stock's volatility is its "beta".

FLDM.US volatility(beta: 1.17)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fluidigm Corporation's is 1.1652. This would suggest that Fluidigm Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Fluidigm Corporation overview

Fluidigm Corporation creates, manufactures, and markets technologies and life sciences tools worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, Hyperion tissue imager, and flow conductor; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow. , as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. Fluidigm Corporation sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site